White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
By Lisa OmAI deploymentGovernanceContinuous compliance

Clinical-Stage Oncology Company Automates Regulated IT Workflows with ProcessX

A clinical-stage precision oncology company used ProcessX to move from two urgent regulated IT workflow needs to six scalable GxP workflows, while modernizing validation with CSA.

Client profile: Pre-commercial, clinical-stage precision oncology company with minimal existing IT systems and a need to scale regulated GxP operations rapidly.

Clinical-Stage Oncology Company Automates Regulated IT Workflows with ProcessX graphic

Executive takeaway

A clinical-stage oncology company asked for two regulated GxP IT workflows and got six, plus a modernized Computer Software Assurance validation methodology that saved significant time and money and now scales with the business.

Workflows requested

2

The original need was for regulated GxP IT Change Management and User Access Provisioning.

Workflows delivered

6

USDM delivered the initial workflows plus Incident Management, Cybersecurity Incidents, Regulatory Assessment, and Periodic Review.

Added ServiceNow licenses

Zero

ProcessX does not require additional ServiceNow licenses, which sped up onboarding for a customer new to the platform.

Before USDM

  • Minimal IT systems in place while clinical results accelerated and demand on IT grew rapidly.
  • No controlled solution for regulated GxP IT Change Management or User Access Provisioning.
  • A traditional, effort-heavy validation methodology that would slow every new system rollout.

After USDM

  • Six regulated GxP workflows running on ProcessX, including Incident Management, Cybersecurity Incidents, Regulatory Assessment, and Periodic Review.
  • A modernized validation methodology using the FDA Computer Software Assurance approach.
  • A scalable GxP and non-GxP workflow solution that evolves with the business without additional ServiceNow licenses.

The Challenge: Regulated IT Had to Scale Before the Business Outgrew It

A pre-commercial, clinical-stage precision oncology company was seeing strong clinical momentum and needed to ramp up IT systems quickly. The company had minimal IT systems in place, but its operating environment already required controlled, auditable workflows for regulated GxP IT Change Management and User Access Provisioning.

The organization was also new to ServiceNow, so the implementation needed to avoid unnecessary licensing drag and validation overhead. Traditional validation would have slowed every new workflow rollout just as the business needed speed, traceability, and reliable data integrity.

  • Two immediate workflow gaps: regulated GxP IT Change Management and User Access Provisioning.
  • ServiceNow adoption pressure: the company needed a fast path without adding avoidable platform complexity.
  • Validation burden: traditional CSV methods would have slowed the IT roadmap and consumed scarce internal bandwidth.

The Approach: ProcessX Workflows with CSA Built Into the Delivery Model

USDM deployed ProcessX to address the initial regulated IT workflow needs and showed the customer how quickly out-of-the-box ProcessX workflows could be configured and maintained for regulated IT operations.

Because the workflow model was straightforward to deploy, the customer expanded the scope from two workflows to six, adding Incident Management, Cybersecurity Incidents, Regulatory Assessment, and Periodic Review. Standing up cybersecurity incident handling as a governed, repeatable workflow also reinforced the company's broader life sciences cybersecurity posture.

Modernizing validation with CSA

During the project, USDM learned that the customer wanted to adopt the FDA's Computer Software Assurance approach. USDM added CSA to the delivery scope, shifting the validation model toward critical thinking, risk-based testing, and reusable evidence rather than low-value documentation. That change helped the team move faster while preserving continuous compliance.

The Results: Six Workflows and a Better Validation Operating Model

The customer's original need was for two GxP workflows. USDM delivered six, modernized the validation methodology, and helped the company avoid additional ServiceNow license requirements through ProcessX.

  • 6 GxP workflows delivered against an initial ask of 2.
  • CSA validation approach adopted to reduce validation effort and focus testing on regulated risk.
  • No additional ServiceNow licenses required by ProcessX, accelerating onboarding for a customer new to the platform.

The company now has a scalable GxP and non-GxP workflow foundation that can evolve with the business. By pairing automated, regulated workflows with a modern validation methodology, the team turned a narrow two-workflow need into a governed operating model for compliant growth.

Regulated IT, Automated

Automate your GxP IT workflows with confidence

USDM helps life sciences teams use ProcessX and CSA to stand up compliant Change Management, User Access, Incident, and Periodic Review workflows without burying the business in validation drag.

Explore ProcessX

Go deeper

Related guidance

Blogs, webinars, and white papers on the capabilities behind this outcome.

Blog

90-Day AI Readiness for Life Sciences

A 90-day AI readiness assessment for life sciences: inventory use cases, classify risk, map data and platform controls, select pilots, and build a governed adoption roadmap.

Read
Blog

Beyond Automation: Orchestrating the Future of Validation with GenAI and ProcessX

How ProcessX helps life sciences teams govern GenAI-enabled validation workflows, agentic actions, Veeva integration, human review, and audit-ready evidence.

Read
White Paper

AI Governance for Life Sciences: Enterprise Framework

Download USDM's AI governance for life sciences white paper for an enterprise framework covering GxP AI governance, vendor risk, lifecycle controls, and compliant AI adoption.

Read
Blog

Boost Efficiency and Anticipate Trends with AI-Driven Predictive Analytics in Life Sciences

AI-driven predictive analytics helps life sciences organizations accelerate drug discovery, sharpen demand forecasting, and reduce manufacturing downtime. Explore the use cases, best practices, and governance steps for putting predictive AI to work.

Read
Blog

Good Machine Learning Practice (GMLP) for Medical Device Development: Guiding Principals

A practical guide to the 10 Good Machine Learning Practice (GMLP) guiding principles for medical device development, plus how ethics, data integrity, and model transparency keep AI-enabled devices safe, reliable, and compliant.

Read
Blog

Is Your Veeva Vault Delivering the Value You Paid For?

How to assess whether your Veeva Vault investment is delivering its full value — configuration maturity, adoption gaps, compliance alignment, and optimization strategies for life sciences organizations.

Read

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.